Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

MRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic. But more broadly, the ...

South Africa's biggest pharmaceutical producer Aspen Pharmacare said on Friday it had reached a 25 million euro ($29.2 ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Steven Hatfill, a senior advisor for the Department of Health and Human Services was fired over the weekend, with health ...

Dr. Hatfill said he was pushed out by Health Secretary Robert F. Kennedy Jr.’s chief of staff, who fired him when he refused ...

Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...

The mRNA vaccines developed to fight COVID-19 during the pandemic "did have a very important impact in decreasing hospitalizations, severe pneumonia and death." ...

FRIDAY, Oct. 24, 2025 (HealthDay News) — The mRNA technology powering some COVID vaccines may hold a surprising benefit for ...